Bimatoprost 0.03% ophthalmic solution prior authorization
Customize your policy alerts
Sign up for all careoregon policy alerts
Know when careoregon releases new policies or updates existing guidance.
Monitor payer policy activity
Prior authorization guideline for coverage and step-therapy requirements for bimatoprost 0.03% ophthalmic solution for CareOregon members.
No material clinical or coverage changes in this revision.
Coverage Criteria
Initial Approval Criteria
Covered when ALL of the following are met
Approval length: approve for life once criteria met
Provider Actions and Authorization Requirements
Prior authorization with step therapy required
Prior authorization is required for bimatoprost 0.03% and approval is contingent on documented trial and failure of latanoprost.
Step therapy prerequisite: latanoprost trial required
This policy uses step therapy: the patient must have tried and failed latanoprost before bimatoprost 0.03% will be approved.
Document prior trial and failure of latanoprost
Include documentation showing a prior trial and failure of latanoprost when submitting the prior authorization request.
- Evidence of trial and clinical reason for failure (e.g., inadequate IOP response, intolerance, or adverse effects)
Denial risk if step therapy not met
If a prior trial and failure of latanoprost is not documented, the request for bimatoprost 0.03% may be denied.
Background
Bimatoprost 0.03% ophthalmic solution is a prostaglandin analog used to lower intraocular pressure in patients with glaucoma or ocular hypertension. This guideline frames bimatoprost 0.03% as a step therapy alternative: prior authorization is required and approval is contingent upon documentation that the patient has tried and failed therapy with latanoprost. Once the approval criteria are met, the medication is authorized for life.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.